MoonLake ImmunotherapeuticsMLTX

Market cap

$895.64M

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	1	666,790	40	451	180
Marketable securities, current	-	-	33	60	268
Total cash & short-term investments	1	666,790	72	511	448
Total current assets	2	793,706	77	514	474
Property, plant and equipment, net	-	-	49,389	320,865	722,226
Total non-current assets	115	115	331,969	12	4
Total assets	117	116	77	527	478
Total current liabilities	125,183	4	8	10	22
Total non-current liabilities	4	4	411,157	3	2
Total liabilities	4	8	8	13	25
Common stock and paid-in capital	5	42	129	610	677
Retained earnings	-90,838	-7,059,268	-80,650,212	-116,657,472	-235,592,989
Stockholders' equity	5	-7,058,937	69	513	453